| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.27 | 4e-15 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-14 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-13 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-12 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-12 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.29 | 1e-11 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.26 | 2e-11 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.22 | 7e-11 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-10 |